Skip to main content

Moors & Cabot, Inc.

Position in ABBV — AbbVie Inc.

CIK 1607239 BOSTON, MA

Position in ABBV

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$17,795,225
+$2,507,636 QoQ
Shares Held
70,717
+0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#667
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2023
CallValue
$1,610
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. ABBV ranks #3 (15.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
70,717 $17,795,225

All Filings in ABBV

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,795,225 70,717
2026-03-31 $15,287,589 70,291
2025-12-31 $15,725,824 68,825
2025-09-30 $15,816,034 68,308
2025-06-30 $12,201,359 65,733
2025-03-31 $13,943,136 66,548
2024-12-31 $11,640,593 65,507
2024-09-30 $12,821,586 64,926
2024-06-30 $11,596,295 67,609
2024-03-31 $12,895,047 70,813
2023-12-31 $10,952,194 70,673
2023-09-30 $10,716,817 71,896
2023-06-30 $9,345,142 69,362
2023-03-31 $11,371,049 71,350
2023-03-31 $1,610 100
2022-12-31 $6,550 500
2022-12-31 $11,519,722 71,281
2022-09-30 $9,579,372 71,376
2022-09-30 $2,000 500
2022-06-30 $11,158,624 72,856
2022-03-31 $12,119,343 74,760
2021-12-31 $10,565,126 78,029
2021-09-30 $8,113,226 75,213
2021-06-30 $7,643,975 67,862
2021-03-31 $7,286,019 67,326
2020-12-31 $6,774,558 63,225
2020-09-30 $4,991,053 56,982
2020-06-30 $5,035,259 51,286
2020-06-30 $7,000 2,100
2020-03-31 $3,305,807 43,389